ATE312104T1 - Verbindungen zur behandlung von beeinträchtigten fundischen entspannung - Google Patents

Verbindungen zur behandlung von beeinträchtigten fundischen entspannung

Info

Publication number
ATE312104T1
ATE312104T1 AT01962742T AT01962742T ATE312104T1 AT E312104 T1 ATE312104 T1 AT E312104T1 AT 01962742 T AT01962742 T AT 01962742T AT 01962742 T AT01962742 T AT 01962742T AT E312104 T1 ATE312104 T1 AT E312104T1
Authority
AT
Austria
Prior art keywords
compounds
treatment
fundic relaxation
impaired fundic
impaired
Prior art date
Application number
AT01962742T
Other languages
English (en)
Inventor
Emelen Kristof Van
Bruyn Marcel F L De
Manuel J Alcazar-Vaca
Jose I Andres-Gil
F J Fernandez-Gadea
M E Matesanz-Ballesteros
J M Bartolome-Nebreda
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE312104T1 publication Critical patent/ATE312104T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
AT01962742T 2000-06-22 2001-06-13 Verbindungen zur behandlung von beeinträchtigten fundischen entspannung ATE312104T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202180 2000-06-22
PCT/EP2001/006749 WO2001098306A1 (en) 2000-06-22 2001-06-13 Compounds for treating impaired fundic relaxation

Publications (1)

Publication Number Publication Date
ATE312104T1 true ATE312104T1 (de) 2005-12-15

Family

ID=8171674

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01962742T ATE312104T1 (de) 2000-06-22 2001-06-13 Verbindungen zur behandlung von beeinträchtigten fundischen entspannung

Country Status (33)

Country Link
US (2) US7081453B2 (de)
EP (1) EP1296987B1 (de)
JP (1) JP4911860B2 (de)
KR (1) KR100821107B1 (de)
CN (2) CN100516066C (de)
AR (1) AR032158A1 (de)
AT (1) ATE312104T1 (de)
AU (1) AU783292B2 (de)
BG (1) BG65895B1 (de)
BR (1) BR0111859B1 (de)
CA (1) CA2410233C (de)
CZ (1) CZ305005B6 (de)
DE (1) DE60115647T2 (de)
EA (1) EA005760B1 (de)
EE (1) EE04878B1 (de)
EG (1) EG24462A (de)
ES (1) ES2254467T3 (de)
HR (1) HRP20020988B1 (de)
HU (1) HU227398B1 (de)
IL (2) IL153559A0 (de)
IS (1) IS2618B (de)
JO (1) JO2352B1 (de)
MX (1) MXPA02012844A (de)
MY (1) MY155267A (de)
NO (1) NO328547B1 (de)
NZ (1) NZ522519A (de)
PA (1) PA8519601A1 (de)
PL (1) PL201656B1 (de)
SA (1) SA01220442B1 (de)
SK (1) SK287730B6 (de)
UA (1) UA74576C2 (de)
WO (1) WO2001098306A1 (de)
ZA (1) ZA200210303B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73123C2 (en) 1999-06-02 2005-06-15 Janssen Pharmaceutica Nv Derivatives of benzodioxane, benzofuran or benzopyran substituted by pyrolidinyl, piperidinyl or homopiperidinyl
DK1187829T3 (da) * 1999-06-02 2004-04-13 Janssen Pharmaceutica Nv Aminoalkylsubstituerede (benzodioxan, benzofuran eller benzopyran) derivater
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
CN101880277A (zh) 2003-04-24 2010-11-10 因塞特公司 作为金属蛋白酶抑制剂的氮杂螺烷衍生物
JP4896476B2 (ja) * 2005-09-16 2012-03-14 広栄化学工業株式会社 メチルオキシメチルアミノピリジン誘導体及びその製造方法
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
KR20100017766A (ko) * 2007-05-10 2010-02-16 에이엠알 테크놀로지, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤조-1,4-디아제핀 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 이의 용도
SG11201401531RA (en) 2011-11-11 2014-07-30 Pfizer 2-thiopyrimidinones
BR112017022340A2 (pt) 2015-05-05 2018-07-10 Pfizer 2-tiopirimidinonas
CN105481839B (zh) * 2015-11-23 2018-05-11 安徽千和新材料科技发展有限公司 一种光活性环氧啉对映体的制备方法
EP3229193A1 (de) 2016-04-07 2017-10-11 The Boeing Company Computerimplementiertes verfahren und system zur gemeinsamen nutzung von informationen zwischen passagieren und luftverkehrsmanagementakteuren

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
DE2400049A1 (de) * 1974-01-02 1975-07-10 Spumalit Anstalt Transportkasten aus kunststoff, insbesondere fuer flaschen
GR71865B (de) 1978-03-20 1983-07-07 Ciba Geigy
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
ZA931343B (en) 1992-03-06 1993-09-24 Akzo Nv 1,4-dioxino(2,3-b)pyridine derivatives.
US6403103B1 (en) * 1994-08-12 2002-06-11 Bio Merieux Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
DK1187829T3 (da) 1999-06-02 2004-04-13 Janssen Pharmaceutica Nv Aminoalkylsubstituerede (benzodioxan, benzofuran eller benzopyran) derivater
UA73123C2 (en) 1999-06-02 2005-06-15 Janssen Pharmaceutica Nv Derivatives of benzodioxane, benzofuran or benzopyran substituted by pyrolidinyl, piperidinyl or homopiperidinyl
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus

Also Published As

Publication number Publication date
HU227398B1 (hu) 2011-05-30
IL153559A0 (en) 2003-07-06
BG107313A (bg) 2003-06-30
MXPA02012844A (es) 2003-05-15
EP1296987A1 (de) 2003-04-02
BR0111859B1 (pt) 2015-01-06
ES2254467T3 (es) 2006-06-16
JO2352B1 (en) 2006-12-12
IL153559A (en) 2008-03-20
EG24462A (en) 2009-07-16
MY155267A (en) 2015-09-30
ZA200210303B (en) 2004-03-19
PL201656B1 (pl) 2009-04-30
BR0111859A (pt) 2003-05-13
DE60115647D1 (de) 2006-01-12
US7423048B2 (en) 2008-09-09
DE60115647T2 (de) 2006-08-24
AU783292B2 (en) 2005-10-13
NO328547B1 (no) 2010-03-15
US7081453B2 (en) 2006-07-25
CZ2003115A3 (cs) 2003-06-18
CZ305005B6 (cs) 2015-03-25
EE04878B1 (et) 2007-08-15
HK1057896A1 (en) 2004-04-23
JP2004501157A (ja) 2004-01-15
CN1781921A (zh) 2006-06-07
US20060142318A1 (en) 2006-06-29
PL358886A1 (en) 2004-08-23
CA2410233C (en) 2011-01-25
HRP20020988A2 (en) 2005-02-28
CN100516066C (zh) 2009-07-22
CA2410233A1 (en) 2001-12-27
KR100821107B1 (ko) 2008-04-14
BG65895B1 (bg) 2010-04-30
US20040019051A1 (en) 2004-01-29
AR032158A1 (es) 2003-10-29
HRP20020988B1 (en) 2011-06-30
EA005760B1 (ru) 2005-06-30
SA01220442B1 (ar) 2008-05-21
AU8386401A (en) 2002-01-02
NZ522519A (en) 2003-09-26
KR20030007566A (ko) 2003-01-23
WO2001098306A1 (en) 2001-12-27
IS6591A (is) 2002-10-25
IS2618B (is) 2010-04-15
SK492003A3 (en) 2003-07-01
EP1296987B1 (de) 2005-12-07
SK287730B6 (en) 2011-07-06
JP4911860B2 (ja) 2012-04-04
NO20026219L (no) 2003-02-17
EE200200694A (et) 2004-06-15
HUP0301185A3 (en) 2009-03-30
NO20026219D0 (no) 2002-12-23
HUP0301185A2 (hu) 2003-08-28
CN1288157C (zh) 2006-12-06
PA8519601A1 (es) 2002-08-26
CN1437602A (zh) 2003-08-20
EA200300049A1 (ru) 2003-04-24
UA74576C2 (en) 2006-01-16

Similar Documents

Publication Publication Date Title
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60138129D1 (de) Apparat zur behandlung von zähnen
DE60035378D1 (de) Gerät zur Behandlung von Bandscheiben
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
EP1274444A4 (de) Arzneistoffe zur behandlung psychiatrischer oder abusus-bedingter störungen
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60141230D1 (de) Verwendung von Botulinum Toxin zur Behandlung von neuralgischen Schmerzen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE293610T1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE251903T1 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
ATE323661T1 (de) Behandlung von mineralischen stoffen
DE60208221D1 (de) Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE60208186D1 (de) Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrinvermittelten erkrankungen
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
ATE312104T1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
ATE423099T1 (de) Zur behandlung von schmerzen geeignete piperazine
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties